GlassScriptPhysician profile
Paul V Ledesma
NPI 1629056981
$35,923.50
in general payments reported to CMS, 2019-2025
51 companies · $1,453 in 2025
The $1,453 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,333 · 2020: $609 · 2021: $747 · 2022: $1,734 · 2023: $858 · 2024: $29K · 2025: $1,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $28K · Food and Beverage: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $28,000.00 |
| Food and Beverage | $3,500.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $28,000.00 | 2024 | |
| Triad Life Sciences INC. | $1,184.21 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $975.04 | 2019 | |
| Abbvie INC. | $900.62 | 2021-2025 | |
| Stryker Corporation | $459.90 | 2020-2025 | Ortholoc 3di, Na, Fixos |
| Electronic Waveform Lab, INC. | $414.33 | 2024-2025 | |
| Djo, LLC | $326.07 | 2020-2025 | Cmf |
| Organogenesis INC. | $282.72 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $274.01 | 2021-2025 | Nuzyra |
| Integra Lifesciences Corporation | $249.83 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Orthofix Medical, INC. | $212.25 | 2019-2025 | Physio-Stim |
| Horizon Therapeutics Plc | $201.18 | 2022-2023 | Krystexxa |
| Amgen INC. | $168.49 | 2024-2025 | Krystexxa |
| Depuy Synthes Sales INC. | $162.17 | 2019-2025 | Motoband |
| Vaporox, INC. | $155.50 | 2020-2024 | Vht-200 Wound Treatment System |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $149.44 | 2019 | |
| Arteriocyte Medical Systems, INC. | $145.50 | 2024-2025 | Magellan |
| Bioventus LLC | $133.09 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $130.12 | 2020-2025 | Tapestry, Allograft |
| Smith+Nephew, INC. | $125.02 | 2019-2024 | Evos, Collagenase Santyl |
| Nevro Corp. | $123.49 | 2023-2024 | Senza |
| Kerecis Limited | $115.62 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kowa Pharmaceuticals America, INC. | $83.55 | 2022-2023 | Seglentis |
| Mimedx Group, INC. | $79.72 | 2024-2025 | |
| Advanced Oxygen Therapy INC. | $73.77 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Dynasplint Systems INC. | $70.59 | 2021 | |
| Next Science LLC | $60.50 | 2022-2023 | Xperience, Surgx, Blastx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $58.54 | 2021-2023 | Jublia |
| Forthright Medical - Az, LLC | $58.54 | 2024 | |
| Wright Medical Technology, INC. | $57.44 | 2019 | |
| Abbott Laboratories | $50.57 | 2023-2024 | Octrode, Proclaim |
| Fusion Orthopedics USA, LLC | $45.65 | 2025 | |
| Medtronic, INC. | $42.30 | 2021-2023 | Intellis Adaptivestim |
| Illuminoss Medical, INC. | $33.05 | 2022-2023 | Photodynamic Bone Stabilization Procedure Pack |
| Vertex Pharmaceuticals Incorporated | $29.88 | 2025 | |
| Averitas Pharma INC. | $29.00 | 2023 | Qutenza |
| Arthrosurface Incorporated | $28.72 | 2020 | |
| Celularity INC. | $28.61 | 2020 | |
| Ibsa Pharma INC. | $20.83 | 2024 | Licart, Flector, Tirosint |
| Misonix INC | $18.06 | 2021 | |
| Osteomed LLC | $17.69 | 2021 | |
| Biotissue Holdings INC. | $17.15 | 2022 | |
| Aap Implants INC | $17.00 | 2021 | |
| Boston Scientific Corporation | $15.76 | 2019 | |
| Orpyx Medical Technologies US INC. | $15.32 | 2023 | Orpyx Si |
| Osteocentric Technologies, INC. | $14.56 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| International Rehabilitative Sciences, INC | $14.49 | 2025 | Rs-4i Plus With Intersperse |
| Endo Pharmaceuticals INC. | $14.46 | 2020 | |
| Kci USA, INC. | $14.12 | 2022 | |
| Reprise Biomedical, INC. | $13.74 | 2024 | Miro3d |
| Melinta Therapeutics, LLC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Ledesma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.